Related Experiment Video
Updated: Jul 8, 2026

Microfluidic Approach to Resolve Simultaneous and Sequential Cytokine Secretion of Individual Polyfunctional Cells
Published on: March 8, 2024
An analytical workflow for investigating cytokine profiles
Janet C Siebert1, Margaret Inokuma, Dan M Waid
1CytoAnalytics, Analytical Services, Denver, Colorado 80209, USA. jsiebert@cytoanalytics.com
Insights
Analyzing T-cell cytokine expression reveals key immune differences in type 1 diabetes and breast cancer. This workflow enhances understanding of disease-related immunologic signaling for potential diagnostics and therapeutics.
Area of Science:
- Immunology
- Computational Biology
- Data Science
Background:
- Cytokine profiles offer insights into immune signaling in disease.
- Multiparameter flow cytometry and bead-based assays enable cytokine measurement.
- Advanced analytical techniques are crucial for interpreting complex cytokine data.
Purpose of the Study:
- To present an analytical workflow for revealing significant alterations in T-cell cytokine expression patterns.
- To demonstrate the workflow's utility in type 1 diabetes (T1D) and breast cancer studies.
- To highlight how this workflow uncovers otherwise unapparent biological findings.
Main Methods:
- A workflow involving population-level and donor-level analysis, data transformation (stratification, normalization), and return to population-level analysis.
- Application in T1D using cytokine bead arrays and in breast cancer using intracellular cytokine staining.
- Data integration into a relational database with metadata and clinical parameters, analyzed using custom Java software.
Main Results:
- In T1D, donor stratification based on unstimulated cytokine expression revealed significant differences in IL-10, IL-1 beta, IL-8, and TNF beta production.
- In breast cancer, data normalization enabled comparisons showing decreased IFN gamma and increased IL-2 expression in T cells stimulated with tumor-associated antigens versus infectious disease antigens.
- The workflow identified statistically significant and biologically relevant immune response patterns.
Conclusions:
- The described analytical workflow effectively reveals significant alterations in T-cell cytokine expression.
- This approach provides statistically supported and biologically relevant findings in complex disease contexts.
- The workflow has potential for advancing diagnostics and therapeutics by understanding disease-related immunologic signaling.
Abstract:
Understanding cytokine profiles of disease states has provided researchers with great insight into immunologic signaling associated with disease onset and progression, affording opportunities for advancement in diagnostics and therapeutic intervention. Multiparameter flow cytometric assays support identification of specific cytokine secreting subpopulations. Bead-based assays provide simultaneous measurement for the production of ever-growing numbers of cytokines. These technologies demand appropriate analytical techniques to extract relevant information efficiently. We illustrate the power of an analytical workflow to reveal significant alterations in T-cell cytokine expression patterns in type 1 diabetes (T1D) and breast cancer. This workflow consists of population-level analysis, followed by donor-level analysis, data transformation such as stratification or normalization, and a return to population-level analysis. In the T1D study, T-cell cytokine production was measured with a cytokine bead array. In the breast cancer study, intracellular cytokine staining measured T cell responses to stimulation with a variety of antigens. Summary statistics from each study were loaded into a relational database, together with associated experimental metadata and clinical parameters. Visual and statistical results were generated with custom Java software. In the T1D study, donor-level analysis led to the stratification of donors based on unstimulated cytokine expression. The resulting cohorts showed statistically significant differences in poststimulation production of IL-10, IL-1 beta, IL-8, and TNF beta. In the breast cancer study, the differing magnitude of cytokine responses required data normalization to support statistical comparisons. Once normalized, data showed a statistically significant decrease in the expression of IFN gamma on CD4+ and CD8+ T cells when stimulated with tumor-associated antigens (TAAs) when compared with an infectious disease antigen stimulus, and a statistically significant increase in expression of IL-2 on CD8+ T cells. In conclusion, the analytical workflow described herein yielded statistically supported and biologically relevant findings that were otherwise unapparent.

